XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements Of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common shares at par value
Additional paid-in capital
Other reserves
Treasury shares
Retained earnings
Accumulated other comprehensive loss
Beginning Balance at Jan. 30, 2021 $ 1,190.3 $ 12.6 $ 258.8 $ 0.4 $ (980.2) $ 2,189.2 $ (290.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 138.4         138.4  
Other comprehensive income (loss) 6.9           6.9
Dividends declared: Preferred shares (8.6)         (8.6)  
Net settlement of equity-based awards (14.4)   (14.6)   15.0 (14.8)  
Share-based compensation expense 8.0   8.0        
Ending Balance at May. 01, 2021 1,320.6 12.6 252.2 0.4 (965.2) 2,304.2 (283.6)
Beginning Balance at Jan. 30, 2021 1,190.3 12.6 258.8 0.4 (980.2) 2,189.2 (290.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 455.6            
Other comprehensive income (loss) (54.1)            
Ending Balance at Oct. 30, 2021 1,534.6 12.6 271.8 0.4 (986.3) 2,580.7 (344.6)
Beginning Balance at May. 01, 2021 1,320.6 12.6 252.2 0.4 (965.2) 2,304.2 (283.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 224.6         224.6  
Other comprehensive income (loss) 1.0           1.0
Dividends declared: Common shares (9.5)         (9.5)  
Dividends declared: Preferred shares (8.6)         (8.6)  
Net settlement of equity-based awards 9.9   (2.9)   14.2 (1.4)  
Share-based compensation expense 17.5   17.5        
Ending Balance at Jul. 31, 2021 1,555.5 12.6 266.8 0.4 (951.0) 2,509.3 (282.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 92.6         92.6  
Other comprehensive income (loss) (62.0)           (62.0)
Dividends declared: Common shares (9.5)         (9.5)  
Dividends declared: Preferred shares (8.7)         (8.7)  
Repurchase of common shares (41.1)       (41.1)    
Net settlement of equity-based awards (3.1)   (5.9)   5.8 (3.0)  
Share-based compensation expense 10.9   10.9        
Ending Balance at Oct. 30, 2021 1,534.6 12.6 271.8 0.4 (986.3) 2,580.7 (344.6)
Beginning Balance at Jan. 29, 2022 1,564.0 12.6 231.2 0.4 (1,206.7) 2,877.4 (350.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (83.5)         (83.5)  
Other comprehensive income (loss) 91.2           91.2
Dividends declared: Common shares (9.3)         (9.3)  
Dividends declared: Preferred shares (8.6)         (8.6)  
Repurchase of common shares (268.2)   50.0   (318.2)    
Net settlement of equity-based awards (39.3)   (54.9)   50.7 (35.1)  
Share-based compensation expense 10.5   10.5        
Ending Balance at Apr. 30, 2022 1,256.8 12.6 236.8 0.4 (1,474.2) 2,740.9 (259.7)
Beginning Balance at Jan. 29, 2022 1,564.0 12.6 231.2 0.4 (1,206.7) 2,877.4 (350.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 99.4            
Other comprehensive income (loss) 68.7            
Ending Balance at Oct. 29, 2022 1,358.1 12.6 252.3 0.4 (1,510.2) 2,885.2 (282.2)
Beginning Balance at Apr. 30, 2022 1,256.8 12.6 236.8 0.4 (1,474.2) 2,740.9 (259.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 145.4         145.4  
Other comprehensive income (loss) (4.9)           (4.9)
Dividends declared: Common shares (9.2)         (9.2)  
Dividends declared: Preferred shares (8.6)         (8.6)  
Repurchase of common shares (22.8)       (22.8)    
Net settlement of equity-based awards (1.2)   (3.6)   2.6 (0.2)  
Share-based compensation expense 12.4   12.4        
Ending Balance at Jul. 30, 2022 1,367.9 12.6 245.6 0.4 (1,494.4) 2,868.3 (264.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 37.5         37.5  
Other comprehensive income (loss) (17.6)           (17.6)
Dividends declared: Common shares (9.2)         (9.2)  
Dividends declared: Preferred shares (8.7)         (8.7)  
Repurchase of common shares (20.2)   0.0   (20.2)    
Net settlement of equity-based awards (3.0)   (4.7)   4.4 (2.7)  
Share-based compensation expense 11.4   11.4        
Ending Balance at Oct. 29, 2022 $ 1,358.1 $ 12.6 $ 252.3 $ 0.4 $ (1,510.2) $ 2,885.2 $ (282.2)